{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:17:02Z","timestamp":1790806622809,"version":"4.1.0"},"reference-count":96,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Medical Devices"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/17434440.2025.2585061","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:53:39Z","timestamp":1762012419000},"page":"1309-1321","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy"],"prefix":"10.1080","volume":"22","author":[{"given":"Alexandra","family":"Sawyer","sequence":"first","affiliation":[{"name":"University of Colorado Anschutz Medical Campus","place":["Aurora, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3607-9788","authenticated-orcid":false,"given":"Gregory P.","family":"Forlenza","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus","place":["Aurora, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-2122","authenticated-orcid":false,"given":"R. Paul","family":"Wadwa","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus","place":["Aurora, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31320-5"},{"key":"e_1_3_4_4_1","unstructured":"The National diabetes statistics report website: centers for Disease Control and Prevention. [cited 2024 Dec 12]. Available from: https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00218-2"},{"key":"e_1_3_4_6_1","unstructured":"Diabetes mellitus type 1- level 4 cause: institute for Health Metrics and Evaluation. [cited 2024 Dec 13]. Available from: https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-diabetes-mellitus-type-1-level-4-disease"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05571-8"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S006"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2399"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0384"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3430"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S007"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.08.005"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S009"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.19.2293"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0514"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0495"},{"key":"e_1_3_4_19_1","unstructured":"FDA approves first automated insulin delivery device for type 1 diabetes: U.S. Food & Drug Administration. 2016 [cited 2025 Feb 3]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-automated-insulin-delivery-device-type-1-diabetes"},{"key":"e_1_3_4_20_1","unstructured":"Tandem Mobi. World\u2019s smallest durable insulin delivery system receives FDA clearance [Internet]. Tandem Diabetes Care Inc. [2023 Nov 7]. Available from: https:\/\/investor.tandemdiabetes.com\/news-releases\/news-release-details\/tandem-mobi-worlds-smallest-durable-insulin-delivery-system?_gl=1*nxpaot*_gcl_au*MTQyOTY4NTMwNy4xNzM4MDAzNDgy."},{"key":"e_1_3_4_21_1","unstructured":"Tandem Diabetes Care announces FDA clearance of the t: slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology [Internet]. Tandem Diabetes Care Inc.; 2019 Dec 13. Available from: https:\/\/investor.tandemdiabetes.com\/news-releases\/news-release-details\/tandem-diabetes-care-announces-fda-clearance-tslim-x2-insulin."},{"key":"e_1_3_4_22_1","unstructured":"FDA clears new insulin pump and algorithm-based software to support enhanced automatic insulin delivery. U.S. Food & Drug Administration; 2023 [cited 2025 Jan 31]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-new-insulin-pump-and-algorithm-based-software-support-enhanced-automatic-insulin-delivery"},{"key":"e_1_3_4_23_1","unstructured":"FDA approves first-of-its-kind automated insulin delivery and monitoring system for use in young pediatric patients. U.S. Food & Drug Administration; 2020 [cited 2025 Jan 31]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-its-kind-automated-insulin-delivery-and-monitoring-system-use-young-pediatric"},{"key":"e_1_3_4_24_1","unstructured":"Omnipod 5 for kids and teens: insulet. 2024 [cited 2025 Jan 31]. Available from: https:\/\/www.omnipod.com\/is-omnipod-right-for-me\/kids-and-teens#:~:text=The%20Omnipod%205%20Automated%20Insulin use%20and%20requires%20a%20prescription"},{"key":"e_1_3_4_25_1","unstructured":"Look H. Tidepool loop has received FDA clearance!: tidepool. 2023 [cited 2025 Feb 3]. Available from: https:\/\/www.tidepool.org\/blog\/tidepool-loop-has-received-fda-clearance"},{"key":"e_1_3_4_26_1","unstructured":"CamDiab secures FDA approval for advanced adaptive hybrid closed-loop app CamAPS FX [Internet]. CamDiab Ltd; 2024 May 24. Available from: https:\/\/s3.eu-west-1.amazonaws.com\/admin.camdiab.com\/press.release\/CamDiab+secures+FDA+approval+for+advanced+adaptive+hybrid+closed-loop+app+CamAPS+FX.pdf"},{"key":"e_1_3_4_27_1","unstructured":"Diabeloop obtains CE marking and launches new round of funding: diabeloop. 2018 [cited 2025 Feb 3]. Available from: https:\/\/www.diabeloop.com\/media-press\/press-releases\/diabeloop-obtains-ce-marking-and-launches-new-round-of-funding-2"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211008442"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0100"},{"key":"e_1_3_4_30_1","unstructured":"Tandem Diabetes Care I. Form 8-K. United States Securities and Exchange Commission. 2024."},{"key":"e_1_3_4_31_1","unstructured":"Minimed 780g insulin pump: medtronic. 2025 [cited 2025 Jan 31]. Available from: https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/diabetes\/insulin-pumps\/minimed-780g-insulin-pump.html#:~:text=The%20MiniMed%E2%84%A2%20780G%20system%20is%20approved%20for%20people%20with diabetes%20age%207%20and%20above"},{"key":"e_1_3_4_32_1","unstructured":"T: slim insulin pump technical specifications. Tandem Diabetes Care. 2015 [cited 2025 Feb 3]. Available from: https:\/\/www.tandemdiabetes.com\/docs\/default-source\/collateral\/t-slim-technical-specifications.pdf?sfvrsn=f94d3bd7_6"},{"key":"e_1_3_4_33_1","unstructured":"Control-IQ+ technology: tandem. [cited 2024 Apr 24]. Available from: https:\/\/www.tandemdiabetes.com\/products\/automated-insulin-delivery\/control-iq-plus"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02218-5"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13292"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0360"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231223934"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(22)00005-8"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1667"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0206"},{"key":"e_1_3_4_41_1","unstructured":"FDA clears first device to enable automated insulin dosing for individuals with type 2 diabetes [Internet]. The FDA; 2024. Agency supports broader access to innovative technology in diabetes management. 2024. Available from Aug 26. Available from https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-device-enable-automated-insulin-dosing-individuals-type-2-diabetes"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400200"},{"key":"e_1_3_4_43_1","unstructured":"Tandem Mobi system: tandem Diabetes Care. [cited 2025 Feb 4]. Available from: https:\/\/www.tandemdiabetes.com\/products\/insulin-pumps\/tandem-mobi"},{"key":"e_1_3_4_44_1","unstructured":"Device comparison chart: panther program. 2025 [updated January 2025; cited 2025 Jan 31]. Available from: https:\/\/www.pantherprogram.org\/device-comparison-chart."},{"key":"e_1_3_4_45_1","unstructured":"T: slim X2 insulin pump with Control-IQ technology: tandem Diabetes Care. [cited 2025 Feb 3]. Available from: https:\/\/www.tandemdiabetes.com\/legal\/important-safety-information\/control-iq"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2012.2192930"},{"key":"e_1_3_4_47_1","unstructured":"Control-IQ technology: tandem Diabetes Care. [cited 2025 Feb 4]. Available from: https:\/\/www.tandemdiabetes.com\/docs\/default-source\/quick-reference\/quick-reference-control-iq-tandem-mobi-ml1012939.pdf?sfvrsn=79d2f5d7_4"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0602"},{"key":"e_1_3_4_49_1","unstructured":"Introducing the t: slim X2 insulin pump with basal-IQ technology: tandem diabetes Care. [cited 2025 Feb 7]. Available from: https:\/\/www.tandemdiabetes.com\/community\/blog\/post\/introducing-the-t-slim-x2-insulin-pump-with-basal-iq-technology#:~:text=Jul%2021%2C%202018 predicting%20and%20helping%20prevent%20lows"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0771"},{"key":"e_1_3_4_51_1","volume-title":"In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes","author":"Kovatchev BP","year":"2009","unstructured":"Kovatchev BP, Breton M, Dalla Man C, et al. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. Los Angeles (CA): SAGE Publications Sage CA; 2009."},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300107"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300506"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1445"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1965"},{"key":"e_1_3_4_56_1","volume-title":"Dias web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials","author":"Place J","year":"2013","unstructured":"Place J, Robert A, Ben Brahim N, et al. Dias web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials. Los Angeles (CA): SAGE Publications Sage CA; 2013."},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2076"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0259"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0147"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0817"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2468"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0333"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0883"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12867"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0011"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0424"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1907863"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0124"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004736"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210834"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0558"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2415948"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0097"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1217"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0341"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0388"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.2337\/db22-281-OR"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01618-2"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-025-06366-x"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf265"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111114"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5106107"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0438"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15432"},{"key":"e_1_3_4_85_1","unstructured":"Tandem Diabetes Care receives CE mark for t: slim X2 insulin pump [Internet]. Tandem Diabetes Care Inc.; 2018 Apr 18. Available from: https:\/\/investor.tandemdiabetes.com\/news-releases\/news-release-details\/tandem-diabetes-care-receives-ce-mark-tslim-x2-insulin-pump"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15849"},{"key":"e_1_3_4_87_1","unstructured":"Tandem Diabetes Care announces FDA clearance of Control-IQ+ automated insulin delivery technology for people with type 2 diabetes [Internet]. Tandem Diabetes Care. 2025 Feb 25. Available from: https:\/\/investor.tandemdiabetes.com\/news-releases\/news-release-details\/tandem-diabetes-care-announces-fda-clearance-control-iq"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1159\/000543034"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S007"},{"key":"e_1_3_4_90_1","unstructured":"Tandem source Tandem Diabetes Care: tandem Diabetes Care; 2024 [updated 2024 Aug 5 [cited 2025 Jun 25]. Available from: https:\/\/www.tandemdiabetes.com\/docs\/default-source\/user-guide\/user-guide-tandem-source-personal-mgdl-aw1014831.pdf?sfvrsn=73553bd7_163"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15092"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30167-5"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231156601"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac022"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000840"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1536"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0308"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0320"}],"container-title":["Expert Review of Medical Devices"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17434440.2025.2585061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:53:09Z","timestamp":1777542789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17434440.2025.2585061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/17434440.2025.2585061"],"URL":"https:\/\/doi.org\/10.1080\/17434440.2025.2585061","relation":{},"ISSN":["1743-4440","1745-2422"],"issn-type":[{"value":"1743-4440","type":"print"},{"value":"1745-2422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}